维持性血液透析合并难治性继发性甲状旁腺功能亢进患者腹主动脉钙化相关因素分析
[Abstract]:Objective: to investigate the risk factors of abdominal aortic calcification (AAC) in patients with maintenance hemodialysis (MHD) combined with refractory secondary hyperparathyroidism (r SHPT). Methods: from May 2014 to January 2016, r SHPT patients undergoing parathyroidectomy in China-Japan Friendship Hospital were selected. The general status of the patients was recorded, and the serum total parathyroid hormone (i PTH), serum calcium (Ca), was recorded. Serum phosphorus (P) and bone transformation markers were measured. Bone mineral density (BMD),) was measured and divided into three groups according to AAC score: no calcification, mild calcification and moderate and severe calcification. The difference between the three groups was compared. Results: 82 patients with r SHPT were enrolled in the study. The age was 50.99 卤12.98 years old and the dialysis age was 88.42 卤50.15 months. The incidence of 48.8%.AAC was 63.4% in 40 male patients. Of them, 20 cases (24.4%) were involved in the four segments of L1~L4. Male AAC score was higher (P0. 016). Compared with the non-calcification group, the two groups with calcification were older (P0.001) and longer dialysis age (P0.05); the type I collagen carboxyl terminal peptide (CTX) of mild and moderate calcification group was significantly lower than that of non-calcified group (P0.05). Multiple linear regression analysis showed that AAC was positively correlated with age (r = 0.042), serum phosphorus (r = 0.438), and negatively correlated with CTX (r = 0.100). Conclusion: the incidence of AAC in patients with MHD and r SHPT is high. The elderly, male, high blood phosphorus and low CTX are the risk factors of vascular calcification.
【作者单位】: 山西医科大学;中日友好医院肾内科;中日友好医院放射科;山西省人民医院肾内科;
【基金】:首都临床特色应用研究与成果推广(Z151100004015112)
【分类号】:R581.1;R692
【相似文献】
相关期刊论文 前10条
1 良介;;高骨钙蛋白浓度降低腹主动脉钙化进展[J];实用糖尿病杂志;2013年02期
2 申卫平,林春静,韩盈,丁辽平;高尿酸血症与腹主动脉粥样硬化(96例临床配对分析)[J];中华内分泌代谢杂志;1991年03期
3 周观彦;方海燕;余霞;;维持性血液透析应用肝素致脱发1例[J];中国血液净化;2009年06期
4 苗华;洪虹;潘明明;朱竹先;吕敏;;维持性血液透析患者继发性甲状旁腺功能亢进的治疗观察[J];中国血液净化;2007年01期
5 许志忠;陈永忠;朱再志;李俊;;维持性血液透析患者头孢菌素脑病13例临床分析[J];四川医学;2008年11期
6 黄恬;余毅;;维持性血液透析患者继发性甲状旁腺功能亢进及其治疗[J];世界临床药物;2010年11期
7 徐丽娟;卢晓昭;邹晓荣;李照辉;罗会文;于桂琴;吴雅岚;张晓凤;;维持性血液透析患者甲状腺功能减退症与贫血的临床相关性分析[J];中国血液净化;2013年04期
8 王素霞;孟建中;景颖;吕苏一;高飞;;维持性血液透析发生高渗性非酮症糖尿病昏迷1例[J];实用医药杂志;2010年03期
9 王艳璇;姜洋;;维持性血液透析并发高钾血症38例诊治分析[J];中国误诊学杂志;2008年24期
10 陈永华;庞慧华;朱铭力;陆任华;周文彦;顾乐怡;张伟明;钱家麒;严玉澄;;维持性血液透析患者中代谢综合征发病情况及危险因素分析[J];上海交通大学学报(医学版);2010年05期
相关会议论文 前2条
1 金领微;李占圆;陈辉乐;戴彩香;;维持性血液透析患者骨质梳松的患病率[A];2007年浙沪两地肾脏病学术年会资料汇编[C];2007年
2 金领微;李占圆;陈辉乐;戴彩香;;维持性血液透析患者骨质疏松患病率的临床分析[A];中华医学会第11届全国内科学术会议论文汇编[C];2007年
相关硕士学位论文 前1条
1 张斌;维持性血液透析患者甲状旁腺功能低下影响因素分析[D];山东大学;2015年
,本文编号:2404126
本文链接:https://www.wllwen.com/yixuelunwen/mjlw/2404126.html